From last‑chance therapy to cancer boosters: A 2050 vision of immunoprevention in high‑risk populations Cancer research outreach RESEARCH From last‑chance therapy to cancer boosters: A 2050 vision of immunoprevention in high‑risk populations Muhammad Habiburrahman Jul 23, 2026